Identifying the possible ubiquitination targets of RSPRY1 in this context and detailing the effects of these targets in the TGF-β signaling pathway may provide important information to elucidate the functional mechanism of RSPRY1 and develop therapeutic strategies for SEMD and other related pathologies. Here, TGFB1 is linked to spondyloepimetaphyseal dysplasia.